Serotonin syndrome after concomitant treatment with linezolid and citalopram.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12715317.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Linezolid, a new synthetic antimicrobial, is an important weapon against methicillin-resistant Staphylococcus aureus (MRSA). Although there are reports of serotonin syndrome developing after concomitant use of linezolid and the selective serotonin reuptake inhibitor paroxitene, this report concerns a patient receiving citalopram who developed thrombocytopenia, serotonin syndrome, and lactic acidosis and died following long-term linezolid therapy.
Medical subject headings
- Acetamides
- Citalopram
- Oxazolidinones
- Serotonin Syndrome